| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Affordable Medicines | — | — | — | $172.08M | $180.78M | $180.28M | $150.79M | $190.79M |
| Specialty | $57.9M | $63.3M | $61.3M | $55.21M | $72.25M | $51.43M | $103.7M | $90.25M |
| AvKARE | $25.62M | $28.26M | $23.47M | $28.6M | $33.23M | $42.26M | $42.7M | $39.08M |
| Total | $249.95M | $269.56M | $262.87M | $255.89M | $286.25M | $273.97M | $297.19M | $320.11M |